Navidea Biopharmaceutical... (NAVB)
0.00
-0.00 (-100.00%)
At close: Apr 02, 2025, 9:49 AM
-100.00% (1D)
| Bid | n/a |
| Market Cap | 50.04K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 945 |
| Avg. Volume (20D) | 7,727 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.13 |
| Beta | 1.90 |
About NAVB
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 10, 1992
Employees 11
Stock Exchange AMEX
Ticker Symbol NAVB
Website https://www.navidea.com
